Related Experiment Videos
Stem cell transplantation: supportive care and long-term complications
John R Wingard1, Georgia B Vogelsang, H Joachim Deeg
1University of Florida, HSC, College of Medicine, Gainesville 32610, USA.
Hematology. American Society of Hematology. Education Program
|November 26, 2002
Summary
Hematopoietic stem cell transplant (HSCT) survivors face potential long-term health issues, including infections and chronic graft-versus-host disease (GVHD). Early awareness and management by clinicians are crucial for minimizing complications and improving patient outcomes.
Area of Science:
- Hematology
- Oncology
- Transplantation Medicine
Background:
- Hematopoietic stem cell transplantation (HSCT) activity is increasing, leading to a growing population of survivors.
- Non-transplant clinicians are increasingly involved in the long-term care of HSCT survivors.
- Awareness of potential late sequelae is critical for managing survivor health.
Purpose of the Study:
- To highlight the diverse late effects following HSCT.
- To inform non-transplant clinicians about potential complications in HSCT survivors.
- To emphasize the importance of vigilance in monitoring and managing long-term morbidities.
Main Methods:
- Review of known late sequelae associated with HSCT.
- Identification of common complications and their risk factors.
- Discussion of preventive and treatment strategies.
Main Results:
- Late effects encompass treatment toxicities, infections, endocrine issues, growth impairment, psychosocial disorders, second malignancies, and chronic graft-versus-host disease (GVHD).
- Various risk factors contribute to the development of these late complications.
- Proactive clinical management can mitigate morbidity and mortality.
Conclusions:
- Clinicians must be vigilant for potential late health issues in HSCT survivors.
- Implementing preventive and treatment strategies is essential for optimizing long-term outcomes.
- Effective management of late sequelae improves the quality of life for HSCT survivors.